✦ LIBER ✦

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial

✍ Scribed by Peter Gibbs; Philip R. Clingan; Vinod Ganju; Andrew H. Strickland; Shirley S. Wong; Niall C. Tebbutt; Craig R. Underhill; Richard M. Fox; Steven P. Clavant; Jenny Leung; Minh Pho; Tracey J. Brown

Publisher: Springer
Year: 2010
Tongue: English
Weight: 459 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1303-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in association with de Gramo

Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer : A single-center phase 2 trial

✍ Bruno Vincenzi; Daniele Santini; Antonio Russo; Chiara Spoto; Olga Venditti; Sim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract ## BACKGROUND: The aim of the current study was the investigation of the value of bevacizumab + 5‐fluorouracil(5–FU)/folinic acid in patients with advanced colorectal cancers who have exhausted standard chemotherapy options. ## METHODS: The authors included 48 heavily pretreated pati

A phase I/II trial of vorinostat in comb

A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy

✍ Peter M. Wilson; Anthony El-Khoueiry; Syma Iqbal; William Fazzone; Melissa J. La 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 315 KB

Randomized phase II study of sequential

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

✍ Michael Gubanski; Anders Johnsson; Eva Fernebro; Lianna Kadar; Ingegerd Karlberg 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB